News

All Categories

29 January 2021

“Too risky not to”: After 20 years of bootstrapping, Phocas Software secures massive $45 million in VC funding

News, Smart Company

28 January 2021

Data analytics company Phocas raises $45m

News, The Australian Financial Review

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

News, Media Release

30 November 2020

OneVentures Growth (Equity) Fund V combines capital and executional support to tech companies

News, Media Release

30 November 2020

OneVentures closes first instalment of new $200 million VC fund

News, The Australian Financial Review

30 November 2020

Growth Equity; accelerating the trajectory of Australian technology businesses

Blog Post

23 November 2020

Are Aussie’s conservative towards venture debt? Is it justified?

Blog Post

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

Media Release

06 October 2020

Fresh funds for Qld needle-free vaccine tech start-up Vaxxas

News, The Australian Financial Review

06 October 2020

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

Media Release

26 September 2020

Healthcare investments at record highs amidst SARS-CoV-2 pandemic

Blog Post

07 September 2020

Could Vaxxas’ tiny patches enable a better COVID-19 vaccine?

News

25 August 2020

How Shippit got lean and profitable during COVID

News, The Australian

25 August 2020

Aussie e-bike subscription startup rides away with $16 million in funding and a brand new name to boot

News, Smart Company

25 August 2020

Subscription e-bike venture Bolt Bikes raises $16 million as it rebrands and expands globally

News

25 August 2020

E-bike start-up in the money as clean energy fund leads $16m round

News, The Australian Financial Review

25 August 2020

With $11 million in fresh capital, Bolt Bikes rebrands to Zoomo

News

12 August 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

Media Release

10 August 2020

Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board

Media Release

05 August 2020

OneVentures closes its first venture debt fund, the largest in Australia

News

03 August 2020

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

Media Release

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

Media Release

02 August 2020

Hatchtech gets lice treatment nod from FDA

News, The Australian Financial Review

22 July 2020

OneVentures’ credit fund reaches final close at $80m

News, The Australian Financial Review

decor decor decor
decor decor decor decor decor